SPNORTHIT-Transformation · AI Deployment · ERP

Pharma

GxP validation support, data integrity and controlled change in the documented BCompliant context.

Abstract sketch of pharma: GxP, data integrity and controlled change as process nodes.
Synthetic illustration: abstract sketch with sample data; no customer system.

Needs

  • Reducing validation backlog on digital platforms
  • Computer software assurance with a defensible scope
  • Making data integrity and lineage traceable
  • Controlled change without quality compromise

Scenario

Evidence Flow

Synthetic example

Synthetic example: illustrated demo with sample data; no customer system and no live telemetry.

  1. Source

    Approved source with version and rights (sample dataset)

  2. Requirement/Control

    Derived requirement with control target and owner

  3. Human Review

    Named approver reviews context, conflicts and evidence

  4. Test/Evidence

    Evaluation against ground truth; reproducible result

  5. Approval

    Signed decision with date and evidence index

Synthetic example: a pharma company backlogs validation tasks; the control pack structures scope, evidence plan and controlled-change path – interpretation remains with the customer's qualified persons.

Control context

  • Documented BCompliant/product context: GxP validation support, computer software assurance, data integrity, pharmacovigilance interfaces, controlled change
Free fit evaluation